News
Filter by year:
-
Celestial AI Secures $250 Million Funding to Revolutionize AI Infrastructure with Its Photonic Fabric
-
TRIMTECH Therapeutics raises $31M to advance targeted protein degradation for treatment of neurodegenerative diseases
-
Concerto Biosciences Announces Appointment of Dr. Stewart Campbell to Board of Directors
-
NovoLINC Secures Investments to Assist AI Computing with Groundbreaking Thermal Interface Technology
-
Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer
-
Tignis has been acquired by Cohu to Enhance Data Analytics and AI/ML Platform
-
Ribometrix Strengthens Leadership by appointing William S. Marshall as CEO and Katie Warner as CSO
